119th Congress
H.R. 3082
Evidence-Based Drug Policy Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Dina Titus(D-NV)
- Introduced
- Apr 29, 2025
- Policy area
- Crime and Law Enforcement
- Committees
- House Committee on Energy and Commerce; House Committee on Oversight and Government Reform; House Committee on the Judiciary
- Official text
- Introduced in House · Congress.gov page
Cosponsors (2)
Original cosponsors (1)
- Ilhan Omar (D-MN)
Added later (1)
- Eleanor Holmes Norton (D-DC) · May 20, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.
Latest action(Apr 29, 2025): Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 29, 2025 · House
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Apr 29, 2025
Introduced in House